Format

Send to

Choose Destination
See comment in PubMed Commons below
Antiviral Res. 2013 Aug;99(2):139-48. doi: 10.1016/j.antiviral.2013.04.017. Epub 2013 May 4.

Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, ABL and AMPK.

Author information

1
Institute for Clinical and Molecular Virology, University of Erlangen-Nuremberg, Erlangen, Germany. corina.hutterer@viro.med.uni-erlangen.de

Abstract

Human cytomegalovirus infection can lead to life-threatening clinical manifestations particularly in the immunocompromised host. Current therapy options face severe limitations leading to a continued search for alternative drug candidates. Viral replication is dependent on a balanced interaction between viral and cellular proteins. Especially protein kinases are important regulators of virus-host interaction indicated by remarkable kinome alterations induced upon HCMV infection. Here we report a novel approach of kinome profiling with an outcome that suggests an important role of specific cellular protein kinases, such as AMPK, ABL2 and Aurora A. Inhibition of AMPK and ABL kinases showed a significant reduction, whereas inhibition of Aurora A kinase led to a slight activation of HCMV replication, as measured in a GFP reporter-based replication assay. Furthermore, analysis of the mode of antiviral action suggested a substantial benefit for the efficiency of viral replication at the immediate early (AMPK) or early-late (ABL) phases of HCMV gene expression. In contrast, inhibition of Aurora A kinase promoted an enhancement of viral early-late gene expression, suggesting a putative role of Aurora A signaling in host defense. Thus, the combined data provide new information on host cell kinases involved in viral replication and uncovered potential targets for future antiviral strategies.

KEYWORDS:

Antiviral targets; Host cell kinome; Human cytomegalovirus; Kinase inhibitors; Mass spectrometry-based profiling; Regulatory protein kinases

PMID:
23648710
DOI:
10.1016/j.antiviral.2013.04.017
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center